Guardant Health Inc (GH)
147.18
-2.27 -1.52%
NASDAQ
Feb 26, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 286.73M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.58 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -253.78M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 63.73% |
| Profit Margin (Quarterly) | -119.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 14.75B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 50.04 |
| PE Ratio | -- |
| Price to Book Value | 11.36 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.6209 |
| Free Cash Flow (Quarterly) | -17.84M |
| Return on Equity | Upgrade |
View All GH News
News
-
WireHeadlineTime (ET)
-
MT Newswires02/26 11:20
-
MT Newswires02/25 13:52
-
MT Newswires02/25 13:45
-
Yahoo02/25 11:34
-
Yahoo02/25 06:04
-
Yahoo02/25 00:30
-
Yahoo02/24 16:29
-
MT Newswires02/24 16:24
-
MT Newswires02/24 16:13
-
Yahoo02/24 16:05
-
SA Breaking News02/23 17:35
-
Yahoo02/23 10:24
-
Yahoo02/21 06:17
-
Yahoo02/21 06:12
-
Yahoo02/17 16:03
-
Yahoo02/16 08:05
-
Yahoo02/12 06:01
-
Yahoo02/05 05:52
-
Yahoo02/04 16:03
-
Yahoo02/03 06:10
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/07/2021 | Earnings | Guardant Health Inc First Quarter Earnings Results for 2021 |
| 05/07/2021 | Misc | Guardant Health Inc First Quarter Earnings Conference Call for 2021 |
| 02/24/2021 | Earnings | Guardant Health Inc Fourth Quarter Earnings Result for 2020 |
| 02/24/2021 17:00 EST | Misc | Guardant Health Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/05/2020 | Earnings | Guardant Health Inc Third Quarter Earnings Result for 2020 |
| 11/05/2020 16:30 EST | Misc | Guardant Health Inc Third Quarter Earnings Conference Call for 2020 |
| 08/06/2020 16:30 EDT | Misc | Guardant Health Inc Second Quarter Earnings Conference Call for 2020 |
| 08/06/2020 | Earnings | Guardant Health Inc Second Quarter Earnings Result for 2020 |
| 06/12/2020 09:30 PDT | Misc | Guardant Health Inc Annual General Meeting for 2019 |
| 05/07/2020 17:00 EDT | Misc | Guardant Health Inc First Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.guardanthealth.com
- Investor Relations URL: N/A
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Blend
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 24, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company’s pipeline includes Lunar-1, for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 147.18 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| EDOC | Global X Telemedicine & Digital Hlth ETF | 4.81% |
| BBH | VanEck Vectors Biotech ETF | 4.57% |
| IHF | iShares US Healthcare Providers ETF | 2.36% |
| GTMRX | Goldman Sachs Small/Mid Cap Growth R | 2.11% |
| FXH | First Trust Health Care AlphaDEX® ETF | 1.80% |
| CHCKX | AB Discovery Growth K | 1.64% |
| FSMRX | Franklin Small-Mid Cap Growth R | 1.42% |
| LMPFX | ClearBridge Aggressive Growth FI | 1.29% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.29% |
| VISGX | Vanguard Small Cap Growth Index Inv | 0.58% |
| VBK | Vanguard Small-Cap Growth ETF | 0.58% |
| NAESX | Vanguard Small Cap Index Inv | 0.27% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GH Tweets Stocktwits
Advertisement
